Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer

ClinicalTrials.gov ID: NCT00003968

Public ClinicalTrials.gov record NCT00003968. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 12:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Study of Bryostatin-1 in Metastatic Renal Cell Carcinoma(Summary Last Modified 8/1999)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Phase II trial to study the effectiveness of bryostatin 1 in treating patients who have metastatic kidney cancer. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Study identification

NCT ID
NCT00003968
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Enrollment
35 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1999 (Type not available)
Primary completion
Dec 2003 (Actual)
Completion
Not listed
Last update posted
Feb 8, 2013

Started 1999

United States locations

U.S. sites
17
U.S. states
2
U.S. cities
17
Facility City State ZIP Site status
Hunterdon Regional Cancer Center Flemington New Jersey 08822 —
Kimball Medical Center Lakewood New Jersey 08701 —
South Jersey Hospital - Millville Millville New Jersey 08332 —
Fox Chase Cancer Center at Virtua-Memorial Hospital Burlington County Mount Holly New Jersey 08060 —
Riverview Medical Center Red Bank New Jersey 07701 —
Community Medical Center Toms River New Jersey 08755 —
St. Francis Medical Center Trenton New Jersey 08629 —
Bon Secours-Holy Family Health System Altoona Pennsylvania 16602 —
Delaware County Memorial Hospital Drexel Hill Pennsylvania 19026 —
Pinnacle Health Hospitals Harrisburg Pennsylvania 17105-8700 —
Conemaugh Memorial Hospital Johnstown Pennsylvania 15905 —
Saint Mary Medical Center Langhorne Pennsylvania 19047 —
North Penn Hospital Lansdale Pennsylvania 19446 —
Paoli Memorial Hospital Paoli Pennsylvania 19301-1792 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Pottstown Memorial Regional Cancer Center Pottstown Pennsylvania 19464 —
Reading Hospital and Medical Center Reading Pennsylvania 19612-6052 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00003968, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 8, 2013 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00003968 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →